UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Riluzole in Huntington's disease: a 3-year, randomized controlled study

Annals of neurology, 2007-09, Vol.62 (3), p.262-272

2007

Volltextzugriff (PDF)

Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device

Movement disorders, 2009-03, Vol.24 (4), p.551-556

2009

Volltextzugriff (PDF)

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Movement disorders, 2005-06, Vol.20 (6), p.674-679

2005

Volltextzugriff (PDF)

Spiralometry: Computerized assessment of tremor amplitude on the basis of spiral drawing

Movement disorders, 2010-10, Vol.25 (13), p.2164-2170

2010

Volltextzugriff (PDF)

ASK1 and MAP2K6 as modifiers of age at onset in Huntington’s disease

Journal of molecular medicine (Berlin, Germany), 2008-04, Vol.86 (4), p.485-490

2008

Volltextzugriff (PDF)

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

BMC neurology, 2006-02, Vol.6 (1), p.11-11, Article 11

2006

Volltextzugriff (PDF)

Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease

European journal of nuclear medicine and molecular imaging, 2014-06, Vol.41 (6), p.1210-1220

2014

Volltextzugriff (PDF)

Anhedonia, Depression, and Motor Functioning in Parkinson's Disease During Treatment With Pramipexole

The journal of neuropsychiatry and clinical neurosciences, 2005-05, Vol.17 (2), p.214-220

2005

Volltextzugriff (PDF)

Huntington's disease as caused by 34 CAG repeats

Movement disorders, 2008-04, Vol.23 (6), p.879-881

2008

Volltextzugriff (PDF)

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner

Human genetics, 2007-09, Vol.122 (2), p.175-182

2007

Volltextzugriff (PDF)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease

BMC medical genetics, 2006-11, Vol.7 (1), p.79-79, Article 79

2006

Volltextzugriff (PDF)

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI

Movement disorders, 2007-08, Vol.22 (11), p.1615-1622

2007

Volltextzugriff (PDF)

Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report

Clinical neuropharmacology, 2010-11, Vol.33 (6), p.317-318

2010

Volltextzugriff (PDF)

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)

BMC medical genetics, 2005-10, Vol.6 (1), p.35-35, Article 35

2005

Volltextzugriff (PDF)

Pramipexole in routine clinical practice: A prospective observational trial in Parkinson's disease

CNS drugs, 2003-01, Vol.17 (13), p.965-973

2003

Volltextzugriff (PDF)

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Neurogenetics, 2005-02, Vol.6 (1), p.25-28

2005

Volltextzugriff (PDF)

Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of "fast tapping" is not a suitable parameter

Movement disorders, 2005-03, Vol.20 (3), p.348-354

2005

Volltextzugriff (PDF)

Hyperhomocysteinaemia in treated patients with Huntington's disease

Movement disorders, 2004-02, Vol.19 (2), p.226-228

2004

Volltextzugriff (PDF)

Reply: Quantitative evaluation of the drawing of a spiral on a paper

Movement disorders, 2011-06, Vol.26 (7), p.1369-1370

2011

Volltextzugriff (PDF)

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease

Archives of neurology (Chicago), 2001-09, Vol.58 (9), p.1451

2001

Volltextzugriff (PDF)

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD

Movement disorders, 2004-02, Vol.19 (2), p.226-228

2004

Volltextzugriff (PDF)

Cross sectional PET study of cerebral adenosine A^sub 1^ receptors in premanifest and manifest Huntington's disease

European journal of nuclear medicine and molecular imaging, 2014-06, Vol.41 (6), p.1210

2014

Volltextzugriff (PDF)

Cross sectional PET study of cerebral adenosine A sub(1) receptors in premanifest and manifest Huntington's disease

European journal of nuclear medicine and molecular imaging, 2014-06, Vol.41 (6), p.1210-1220

2014

Volltextzugriff (PDF)

Activity-based diary for Parkinson's disease

Clinical neuropharmacology, 2002-01, Vol.25 (1), p.43-50

2002

Volltextzugriff (PDF)

Der Einsatz von Amisulprid bei Patienten mit Morbus Huntington

Psychiatrische Praxis, 2005-10, Vol.32 (7), p.363-366

2005

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Englisch
(302)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Riluzole in Huntington's disease: a 3-year, randomized controlled study

Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Spiralometry: Computerized assessment of tremor amplitude on the basis of spiral drawing

ASK1 and MAP2K6 as modifiers of age at onset in Huntington’s disease

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease

Anhedonia, Depression, and Motor Functioning in Parkinson's Disease During Treatment With Pramipexole

Huntington's disease as caused by 34 CAG repeats

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI

Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)

Pramipexole in routine clinical practice: A prospective observational trial in Parkinson's disease

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of "fast tapping" is not a suitable parameter

Hyperhomocysteinaemia in treated patients with Huntington's disease

Reply: Quantitative evaluation of the drawing of a spiral on a paper

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD

Cross sectional PET study of cerebral adenosine A^sub 1^ receptors in premanifest and manifest Huntington's disease

Cross sectional PET study of cerebral adenosine A sub(1) receptors in premanifest and manifest Huntington's disease

Activity-based diary for Parkinson's disease

Der Einsatz von Amisulprid bei Patienten mit Morbus Huntington

Suchergebnisse filtern